These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 3822305)

  • 1. Major morbidity after pelvic exenteration: a seven-year experience.
    Roberts WS; Cavanagh D; Bryson SC; Lyman GH; Hewitt S
    Obstet Gynecol; 1987 Apr; 69(4):617-21. PubMed ID: 3822305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indications for primary and secondary exenterations in patients with cervical cancer.
    Marnitz S; Köhler C; Müller M; Behrens K; Hasenbein K; Schneider A
    Gynecol Oncol; 2006 Dec; 103(3):1023-30. PubMed ID: 16890276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pelvic exenteration for primary and recurrent gynaecological malignancies.
    de Wilt JH; van Leeuwen DH; Logmans A; Verhoef C; Kirkels WJ; Vermaas M; Ansink AC
    Eur J Obstet Gynecol Reprod Biol; 2007 Oct; 134(2):243-8. PubMed ID: 16950559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pelvic exenteration, morbidity and survival].
    Méndez L; Bernal A; Escudero P; González G; Fajardo A
    Ginecol Obstet Mex; 1994 Jun; 62():161-5. PubMed ID: 8056362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pelvic exenteration for carcinoma of the cervix.
    Ingersoll FM; Ulfelder H
    N Engl J Med; 1966 Mar; 274(12):648-51. PubMed ID: 17926376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pelvic exenteration for carcinoma of the uterine cervix (author's transl)].
    Mayer M; Bobin JY; Colon J; Borg G
    Bull Cancer; 1980; 67(1):70-7. PubMed ID: 7362891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pelvic exenteration for primary carcinoma of the uterine cervix.
    Deckers PJ; Ketcham AS; Sugerbaker EV; Hoye RC; Thomas LB
    Obstet Gynecol; 1971 May; 37(5):647-59. PubMed ID: 5091743
    [No Abstract]   [Full Text] [Related]  

  • 8. Ileal orthotopic neobladder after pelvic exenteration for cervical cancer.
    Chiva LM; Lapuente F; Núñez C; Ramírez PT
    Gynecol Oncol; 2009 Apr; 113(1):47-51. PubMed ID: 19176235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of pelvic exenteration for sarcomatous malignancies.
    Reid GC; Morley GW; Schmidt RW; Hopkins MP
    Obstet Gynecol; 1989 Jul; 74(1):80-4. PubMed ID: 2733946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Total pelvic exenteration as a therapeutic option in advanced malignant disease of the pelvis.
    Kraybill WG; Lopez MJ; Bricker EM
    Surg Gynecol Obstet; 1988 Mar; 166(3):259-63. PubMed ID: 3344455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of exenterative surgery and urinary diversion in persistent or locally recurrent gynecological malignancy: complications and survival.
    Spahn M; Weiss C; Bader P; Frohneberg D; Studer UE; Burkhard FC
    Urol Int; 2010; 85(1):16-22. PubMed ID: 20299775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pelvic exenteration: ten-year experience at the European Institute of Oncology in Milan.
    Maggioni A; Roviglione G; Landoni F; Zanagnolo V; Peiretti M; Colombo N; Bocciolone L; Biffi R; Minig L; Morrow CP
    Gynecol Oncol; 2009 Jul; 114(1):64-8. PubMed ID: 19411097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Role of pelvic exenterations in the treatment of cervix cancers. Apropos of 41 surgically treated cases].
    Janser JC; Rodier JF; Rodier D; Vergnes Y
    Chirurgie; 1994-1995; 120(8):409-14; 414-5. PubMed ID: 7648894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pelvic exenteration for recurrent endometrial cancer.
    Barakat RR; Goldman NA; Patel DA; Venkatraman ES; Curtin JP
    Gynecol Oncol; 1999 Oct; 75(1):99-102. PubMed ID: 10502433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Operative mortality and morbidity in pelvic exenteration. Technical aspects].
    De Ranieri J; Crouet H; André M; Souloy J; Desdoits JM; Bouvet A
    J Chir (Paris); 1986 Apr; 123(4):246-50. PubMed ID: 3745309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pelvic exenteration: a morbidity and mortality analysis of a seven-year experience.
    Anthopoulos AP; Manetta A; Larson JE; Podczaski ES; Bartholomew MJ; Mortel R
    Gynecol Oncol; 1989 Nov; 35(2):219-23. PubMed ID: 2807013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laparoscopic pelvic exenteration for advanced pelvic cancers: a review of 16 cases.
    Puntambekar S; Kudchadkar RJ; Gurjar AM; Sathe RM; Chaudhari YC; Agarwal GA; Rayate NV
    Gynecol Oncol; 2006 Sep; 102(3):513-6. PubMed ID: 16510172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pelvic exenteration in gynecologic oncology: Experience at the Mount Sinai Center, 1975-1992.
    Dottino PR; Segna RA; Jennings TS; Mandeli JP; Konsker K; Cohen CJ
    Mt Sinai J Med; 1995 Nov; 62(6):431-5. PubMed ID: 8692157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Current status of frequency and complications of pelvic exenterations for recurrent cervico-uterine cancer after radiation].
    Torres-Lobatón A; González-Mendoza RL; Román-Bassaure E; Hernández-Aten D; Rojo-Herrera G
    Ginecol Obstet Mex; 1996 Dec; 64():538-43. PubMed ID: 9019436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Total pelvic exenteration: effective palliation of perineal pain in patients with locally recurrent prostate cancer.
    Kamat AM; Huang SF; Bermejo CE; Rosser CJ; Pettaway CA; Pisters PW; Guitreau D; Pisters LL
    J Urol; 2003 Nov; 170(5):1868-71. PubMed ID: 14532795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.